EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Lactylation Modification and Esophageal Cancer: Research Progress From Hypoxia‐Induced Metabolic Reprogramming to Immune Escape

Xiaowei Liu, Weizhuang Sun, Changyong Li iD, Yang Wang iD

The FASEB Journal · 31.08.2026 · 40 (16)

DOI: 10.1096/fj.202602899r ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FASEB Journal, online erschienen am 20.08.2026. Verfasst von Xiaowei Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital), Dalian, China. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Tumor Escape, Protein Processing, Post-Translational, Hypoxia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esophageal cancer is a common malignancy of the digestive tract, marked by aggressive invasion, unfavorable prognosis, and limited responsiveness to existing therapeutic strategies. Hypoxia‐driven metabolic remodeling represents a key feature of the esophageal cancer microenvironment. In this context, enhanced glycolytic activity leads to lactate accumulation, thereby providing the metabolic substrate for lactylation. Lactylation, a recently recognized lysine post‐translational modification, has been detected on both histone and non‐histone proteins and regulates tumor biology by modulating chromatin accessibility, gene transcription, protein stability, and signaling pathway activity. Emerging evidence suggests that lactylation is closely involved in the malignant progression of esophageal cancer, including tumor cell proliferation, invasion, stemness maintenance, regulation of programmed cell death, immune escape, and treatment resistance. Under hypoxic conditions, increased lactate production may drive histone lactylation, including histone lactylation marks such as H3K9la, H3K18la, and H4K12la, as well as lactylation of non‐histone proteins. These modifications contribute to remodeling of the immunosuppressive tumor microenvironment and weaken anti‐tumor immune responses. This review highlights the biological basis of lactate metabolism and lactylation, focusing on their roles in metabolic reprogramming driven by hypoxia, the advancement of tumors, the regulation of the immune microenvironment, immune evasion, and resistance to therapy in esophageal cancer. Additionally, we explore the potential clinical significance of molecules associated with lactylation as diagnostic markers and therapeutic targets, offering fresh insights for precision treatment strategies in esophageal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsTumor EscapeProtein Processing, Post-TranslationalHypoxiaHumansMetabolic ReprogrammingAnimalsTumor MicroenvironmentHistones

Stichwörter der Autor:innen

esophageal cancerhypoxiaimmune evasionlactylation modificationsmetabolic reprogramming

Substanzen

Histones

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital), Dalian, China.
  • Institute of Rehabilitation Medicine, Qilu Medical University, Zibo, China.

ORCID-Profile: Changyong Li, Yang Wang

Zitieren

APA

Liu, X., Sun, W., Li, C., & Wang, Y. (2026). Lactylation Modification and Esophageal Cancer: Research Progress From Hypoxia‐Induced Metabolic Reprogramming to Immune Escape. The FASEB Journal, 40(16). https://doi.org/10.1096/fj.202602899r

Vancouver

Liu X, Sun W, Li C, Wang Y. Lactylation Modification and Esophageal Cancer: Research Progress From Hypoxia‐Induced Metabolic Reprogramming to Immune Escape. The FASEB Journal. 2026;40(16). doi:10.1096/fj.202602899r

BibTeX
@article{Liu2026,
  author = {Liu, Xiaowei and Sun, Weizhuang and Li, Changyong and Wang, Yang},
  title = {Lactylation Modification and Esophageal Cancer: Research Progress From Hypoxia‐Induced Metabolic Reprogramming to Immune Escape},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {16},
  doi = {10.1096/fj.202602899r}
}
Kostenlos starten →